corticosteroids

Immune mechanisms in allergic eye diseaseOcular allergy affects the quality of life of millions of people every year. Understanding the different mechanisms involved will increase their future therapeutic options.
Survey uncovers lupus corticosteroid treatment issuesPatients with systemic lupus erythematosus often self-manage their corticosteroid medication without the consent of their healthcare providers, according to a recent multicountry survey.
Two asthma treatment recommendations for health organizationsAllergist Bradley Chipps, MD, shares research on how to fine-tune asthma management strategies.
Steroid and NSAID combination prevents macular oedema after cataractsA combination of a topical corticosteroid and a nonsteroidal anti-inflammatory drug (NSAID) is more effective than either one alone in reducing the risk of cystoid macular oedema (CME) after cataract surgery in nondiabetic patients, researchers say.
Applying micropulse transscleral cyclophotocoagulation for early-stage glaucoma Micropulse transscleral cyclophotocoagulation utilises a different delivery modality than its predecessor, continuous-wave laser cycloablation, to produce a biological reaction without the lethal effects caused by thermal buildup.
Topical corticosteroids reduce retinoid irritation, study showsTransient topical corticosteroids could take edge off severe irritation from topical retinoid acne treatment without decreasing efficacy.
Optimal topical retinoid use for acneStriking the perfect balance for retinoid use isn't easy. In this article, Dr. Michael Kolodney outlines his techniques for applying and managing retinoids.
Role of corticosteroids uncertain in AMD managementThere is no doubt that inflammation is a component of age-related macular degeneration (AMD), and yet the role of corticosteroid treatment in the management of eyes with AMD remains uncertain, said Marc de Smet, MD, PhD.
European Commission approves adalimumab for paediatric uveitisThe European Commission has approved adalimumab (Humira, AbbVie) as the first biologic treatment for chronic non-infectious anterior uveitis in paediatric patients from 2 years of age who have had an inadequate response to conventional therapy.
Pediatricians could be overprescribing combination antifungal/corticosteroidsA review of a large claims-based database suggests that they are. Investigators identified almost 10,000 children aged up to 14 years who were prescribed either Lotrisone or Mycolog-II creams (antifungal and corticosteroid combination products) by pediatricians and other specialists from 2007 through 2014.